The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combined treatment using the anti-p53 drug, APR-246 and eribulin: Synergistic growth inhibition in p53-mutated breast cancer cells.
 
Naoise C Synnott
No Relationships to Disclose
 
Alyson M. Murray
No Relationships to Disclose
 
Norma O'Donovan
Research Funding - Eisai
 
Michael J. Duffy
No Relationships to Disclose
 
John Crown
Research Funding - Boehringer Ingelheim; Eisai; GlaxoSmithKline; Roche